Preprocedural DOAC plasma levels and to which extend they predict the risk of periprocedural blood loss
dc.rights.license | CC-BY-NC-ND | |
dc.contributor.advisor | Kempen, Thomas | |
dc.contributor.author | Schoot, Yvette | |
dc.date.accessioned | 2024-04-25T00:01:41Z | |
dc.date.available | 2024-04-25T00:01:41Z | |
dc.date.issued | 2024 | |
dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/46322 | |
dc.description.sponsorship | Utrecht University | |
dc.language.iso | EN | |
dc.subject | Currently, Direct oral anticoagulants (DOACs) users undergoing elective procedures interrupt therapy according to a standard perioperative protocol. However, patients may benefit from preprocedural DOAC monitoring to reduce the bleeding risk during the surgery, since in ~ 9 – 23% of patients DOAC levels are still elevated before surgery. The aim of this study was to determine preprocedural DOAC levels and to which extend residual DOAC levels predict the risk of periprocedural blood loss. | |
dc.title | Preprocedural DOAC plasma levels and to which extend they predict the risk of periprocedural blood loss | |
dc.type.content | Master Thesis | |
dc.rights.accessrights | Open Access | |
dc.subject.courseuu | Pharmacy | |
dc.thesis.id | 30324 |